294 related articles for article (PubMed ID: 16330610)
1. Parkinsonism with intramuscular ziprasidone.
Bilal L; Tsai C; Gasper JJ; Ndlela JC
Am J Psychiatry; 2005 Dec; 162(12):2392-3. PubMed ID: 16330610
[No Abstract] [Full Text] [Related]
2. Ziprasidone-induced acute dystonia.
Mason MN; Johnson CE; Piasecki M
Am J Psychiatry; 2005 Mar; 162(3):625-6. PubMed ID: 15741487
[No Abstract] [Full Text] [Related]
3. Third degree heart block following intramuscular ziprasidone.
Tambyraja R; Strawn JR
Schizophr Res; 2011 Feb; 125(2-3):302-3. PubMed ID: 20692812
[No Abstract] [Full Text] [Related]
4. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
Oechsner M; Korchounov A
Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
[TBL] [Abstract][Full Text] [Related]
5. [Ziprasidone-augmentation of clozapine].
Zink M; Mase E; Dressing H
Psychiatr Prax; 2004 Jul; 31(5):259-61. PubMed ID: 15243877
[TBL] [Abstract][Full Text] [Related]
6. Clozapine and ziprasidone: a useful combination in patients with treatment-resistant schizophrenia.
Ziegenbein M; Calliess IT
J Neuropsychiatry Clin Neurosci; 2006; 18(2):246-7. PubMed ID: 16720806
[No Abstract] [Full Text] [Related]
7. A case of catatonia successfully treated with ziprasidone, in a patient with DSM-IV delusional disorder.
Angelopoulos EK; Corcondilas M; Kollias CT; Kioulos KT; Bergiannaki JD; Papadimitriou GN
J Clin Psychopharmacol; 2010 Dec; 30(6):745-6. PubMed ID: 21057243
[No Abstract] [Full Text] [Related]
8. Rhabdomyolysis after correction of hyponatremia in psychogenic polydipsia possibly complicated by ziprasidone.
Zaidi AN
Ann Pharmacother; 2005 Oct; 39(10):1726-31. PubMed ID: 16131536
[TBL] [Abstract][Full Text] [Related]
9. Hyperosmolar hyperglycemic state associated with ziprasidone treatment: a case report.
Létourneau G; Abdel-Baki A; Dubreucq S; Mahone M; Granger B
J Clin Psychopharmacol; 2011 Oct; 31(5):671-3. PubMed ID: 21881458
[No Abstract] [Full Text] [Related]
10. Ziprasidone-induced tardive laryngeal dystonia: a case report.
Tsai CS; Lee Y; Chang YY; Lin PY
Gen Hosp Psychiatry; 2008; 30(3):277-9. PubMed ID: 18433661
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole resolves amisulpride and ziprasidone-induced hyperprolactinemia.
Saitis M; Papazisis G; Katsigiannopoulos K; Kouvelas D
Psychiatry Clin Neurosci; 2008 Oct; 62(5):624. PubMed ID: 18950388
[No Abstract] [Full Text] [Related]
12. Sudden death in a patient with Tourette syndrome during a clinical trial of ziprasidone.
Scahill L; Blair J; Leckman JF; Martin A
J Psychopharmacol; 2005 Mar; 19(2):205-6. PubMed ID: 15728441
[No Abstract] [Full Text] [Related]
13. Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.
Schindehütte J; Trenkwalder C
Clin Neurol Neurosurg; 2007 Feb; 109(2):188-91. PubMed ID: 16949733
[TBL] [Abstract][Full Text] [Related]
14. Switching among antipsychotics in everyday clinical practice: focus on ziprasidone.
Rossi A; Cañas F; Fagiolini A; Larmo I; Levy P; Montes JM; Papageorgiou G; Sturlason R; Zink M; Correll CU
Postgrad Med; 2011 Jan; 123(1):135-59. PubMed ID: 21293094
[TBL] [Abstract][Full Text] [Related]
15. Strategies for successful clinical management of schizophrenia with ziprasidone.
Fagiolini A; Cañas F; Gallhofer B; Larmo I; Levy P; Montes JM; Papageorgiou G; Zink M; Rossi A
Expert Opin Pharmacother; 2010 Sep; 11(13):2199-220. PubMed ID: 20658947
[TBL] [Abstract][Full Text] [Related]
16. [Risk of QTc prolongation due to combination of ziprasidone and quetiapine].
Minov C
Psychiatr Prax; 2004 Nov; 31 Suppl 1():S142-4. PubMed ID: 15570533
[TBL] [Abstract][Full Text] [Related]
17. Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service.
Kohen I; Preval H; Southard R; Francis A
Am J Geriatr Pharmacother; 2005 Dec; 3(4):240-5. PubMed ID: 16503319
[TBL] [Abstract][Full Text] [Related]
18. Chronic Pisa syndrome associated with switching antipsychotics from olanzapine to ziprasidone.
Yeh YW; Chen YC; Chen CK; Feng HM; Wang TY; Chen CL
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):162-3. PubMed ID: 19028541
[No Abstract] [Full Text] [Related]
19. Successful switch to aripiprazole after induction of hyperprolactinemia by ziprasidone: a case report.
Anghelescu I; Wolf J
J Clin Psychiatry; 2004 Sep; 65(9):1286-7. PubMed ID: 15367061
[No Abstract] [Full Text] [Related]
20. [Practical aspects of the use of ziprasidone in schizophrenia].
Ochedzan D; Jarema M
Psychiatr Pol; 2010; 44(6):881-93. PubMed ID: 21449170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
